A national register for surveillance of inherited disorders: β thalassaemia in the United Kingdom

Bulletin of the World Health Organization

Volumn 79, Issue 11, 2001, Pages 1006-1013

  Modell, B ^a   Khan, M ^a   Darlison, M ^a   King, A ^a   Layton, M ^a   Old, J ^a   Petrou, M ^a   Varnavides, L ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Beta thalassemia epidemiology; Evaluation studies; Hemoglobinopathies epidemiology; Prenatal diagnosis utilization; Registries; United Kingdom

Indexed keywords

HEMOGLOBIN E;

HEALTH SERVICES;

ADULT; AGED; ARTICLE; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CYPRUS; DATA BASE; ETHNOLOGY; FETUS; GENETIC COUNSELING; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH SURVEY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PAKISTAN; PRENATAL DIAGNOSIS; REGISTER; UNITED KINGDOM;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENOME, HUMAN; GREAT BRITAIN; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; QUALITY OF HEALTH CARE; REGISTRIES;

EID: 0035171882     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Community genetics
2. The history of community genetics: The contribution of the haemoglobin disorders
3. EC concerted action on developing patient registers as a tool for improving service delivery for haemoglobin disorders
4. Guideline: The laboratory diagnosis of haemoglobinopathies
5. Community control of hereditary anaemias: Memorandum from a WHO meeting
6. Population-based genetic screening
7. Current status of thalassaemia and the sickle cell syndromes in Greece
8. Survival and causes of death in thalassaemia major
9. Prevention of thalassaemia in Cyprus
10. The activities of the Hungarian Centre for Congenital Anomaly Control
11. Value of registries in decision making in public health: The example of trisomy 21
12. Genetic disorders in children and young adults: A population study
13. Major factors determining the frequencies of hemoglobinopathies in Oman
14. Incidence of β-thalassaemia trait among Cypriots in London
15. Iron chelation therapy
16. Survival and desferrioxamine in thalassaemia major
17. Mortality and morbidity in thalassaemia with conventional treatment
18. Bone marrow transplantation in patients with thalassaemia
19. Effect of introducing antenatal diagnosis on the reproductive behaviour of families at risk for thalassaemia major
20. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: The first 20 years
21. How well do we manage families with genetic problems? A national confidential enquiry into counselling for genetic disorders should tell us
22. Mapping the prevalence of sickle cell and beta thalassaemia in England: Estimating and validating ethnic-specific rates
23. How thalassaemia was controlled in Cyprus
24. Survival in beta thalassaemia major in the United Kingdom: Data from the UK Thalassaemia Register
25. Combined therapy with deferiprone and desferrioxamine
26. Informed choice in genetic screening for thalassaemia during pregnancy: Audit from a national confidential enquiry